Opti Capital Management, LP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 17 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Opti Capital Management, LP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$8,206,000
-3.5%
8,000,0000.0%0.66%
+2.5%
Q4 2021$8,505,000
+1.5%
8,000,0000.0%0.64%
-18.0%
Q3 2021$8,383,000
-4.1%
8,000,0000.0%0.79%
-16.0%
Q2 2021$8,743,000
-10.7%
8,000,000
-5.9%
0.94%
-21.7%
Q1 2021$9,796,000
-10.6%
8,500,0000.0%1.20%
-2.0%
Q4 2020$10,952,000
+13.2%
8,500,0000.0%1.22%
+3.1%
Q3 2020$9,674,000
-16.9%
8,500,000
+84900.0%
1.18%
-40.5%
Q2 2020$11,641,000
+249.0%
10,000
+233.3%
1.99%
+296.2%
Q2 2019$3,336,0003,0000.50%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 14,800,000$15,353,0001.33%
WOLVERINE ASSET MANAGEMENT LLC 25,939,000$26,873,0000.37%
FARALLON CAPITAL MANAGEMENT LLC 24,130,000$24,718,0000.19%
CSS LLC/IL 2,000,000$2,072,0000.12%
CAPSTONE INVESTMENT ADVISORS, LLC 9,500,000$9,909,0000.09%
Allianz Asset Management GmbH 31,695,000$32,786,0000.03%
AQR Arbitrage LLC 1,500,000$1,565,0000.02%
D. E. Shaw & Co., Inc. 9,443,000$9,776,0000.01%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 9,300,000$9,677,487,0000.01%
Citadel Advisors 13,000,000$13,479,0000.01%
View complete list of PTC THERAPEUTICS INC shareholders